OrthoPediatrics Corp. (KIDS)

Market Cap	536.99M
Revenue (ttm)	212.45M
Net Income (ttm)	-40.68M
Shares Out	24.77M
EPS (ttm)	-1.76
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	167,953
Open	21.92
Previous Close	21.24
Day's Range	21.69 - 21.92
52-Week Range	19.52 - 35.99
Beta	1.10
Analysts	Buy
Price Target	35.71 (+64.56%)
Earnings Date	Aug 4, 2025

About KIDS

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruct...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Oct 12, 2017
• Employees: 562
• Stock Exchange: NASDAQ
• Ticker Symbol: KIDS
• Website: https://www.orthopediatrics.com

Financial Performance

In 2024, OrthoPediatrics's revenue was $204.73 million, an increase of 37.65% compared to the previous year's $148.73 million. Losses were -$37.82 million, 80.3% more than in 2023.

Analyst Summary

According to 7 analysts, the average rating for KIDS stock is "Buy." The 12-month stock price target is $35.71, which is an increase of 64.56% from the latest price.

Price Target

$35.71

(64.56% upside)

Analyst Consensus: Buy